Summary
Definition
History and exam
Key diagnostic factors
- presença de fatores de risco
- febre periódica
- dor abdominal
- hábito intestinal alterado
- edema/dor aguda na articulação
- resposta à colchicina
- lesões cutâneas do tipo erisipela
Other diagnostic factors
- dor torácica pleurítica
- mialgia aguda
- hepatoesplenomegalia
- história de apendicectomia
- cicatrizes abdominais
- dor articular crônica
- atrito pleural
- mialgia/fibromialgia crônica
- cefaleia
- rigidez de nuca
- fotofobia
- dor escrotal aguda + edema
- distúrbios visuais
Risk factors
- ascendência mediterrânea
- idade <20 anos
- sexo masculino
- história familiar positiva
- mutação genética no gene MEFV
- país de origem: Armênia, Turquia ou bacia do Mediterrâneo
- estresse psicológico
- doença viral
- esforço físico
- exaustão extrema
- uso de simpatomiméticos vasoconstritores
Diagnostic tests
1st tests to order
- Hemograma completo
- velocidade de hemossedimentação
- proteína C-reativa
- fibrinogênio sérico
- amiloide A sérica
- TFHs
- análise da urina
Tests to consider
- lactato desidrogenase (LDH)
- radiografia torácica
- radiografia da articulação
- tomografia computadorizada (TC) abdominal
- tomografia computadorizada (TC) do tórax
- ecocardiograma
- ressonância nuclear magnética (RNM) da articulação
- teste genético
Treatment algorithm
ataque agudo
febre familiar do Mediterrâneo (FFM) confirmada
Contributors
Authors
Erkan Demirkaya, MD, MSc, FRCPC
Professor of Paediatrics
Schulich School of Medicine & Dentistry
Department of Paediatrics
Division of Paediatric Rheumatology
University of Western Ontario
London
ON
Canada
Disclosures
ED is an author of a number of references cited in this topic.
Acknowledgements
Dr Erkan Demirkaya would like to gratefully acknowledge Dr Véronique Hentgen and Dr Ghaith Mitri, the previous contributors to this topic.
Disclosures
VH has been reimbursed by Novartis Pharmaceuticals (the manufacturer of canakinumab) for attending several conferences, has received consulting fees from Novartis Pharmaceuticals, and is an author of references cited in this topic. GM declares that he has no competing interests.
Peer reviewers
M. Eric Gershwin, MD
Distinguished Professor of Medicine
The Jack and Donald Chia Professor of Medicine
Chief
Division of Rheumatology, Allergy and Clinical Immunology
Genome and Biomedical Sciences Facility
University of California at Davis
Davis
CA
Disclosures
MEG declares that he has no competing interests.
Isabelle Touitou, MD, PhD
Medical Unit for Autoinflammatory Diseases
Genetic Laboratory
Arnaud de Villeneuve Hospital
Montpellier
France
Disclosures
IT declares that she has no competing interests.
References
Key articles
Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019 Aug;78(8):1025-32.Full text Abstract
Giancane G, Ter Haar NM, Wulffraat N, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015 Apr;74(4):635-41. Abstract
Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016 Apr;75(4):644-51. Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Sarcoidose aguda
- Artrite reumatoide
- Vasculite
More DifferentialsGuidelines
- EULAR recommendations for the management of familial Mediterranean fever
- Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer